A global pharmaceutical company used the pandemic as a springboard to reshape travel behaviours, reducing unnecessary trips while empowering employees with choice.
Find out how we used our expertise in Communications, Change and Listening to help spark this cultural shift and achieve standout results…
The company saw the pandemic travel restrictions as an opportunity to make lasting change. Internal travel – mainly for meetings – accounted for 70% of spend. The challenge was to:
We combined behavioural science with creative employee engagement to reframe travel decisions.
The campaign reached 13 countries in 2022 and within the first year achieved a 52% reduction in travel spend compared with 2019 – equating to £130 million saved.
Beyond financial impact, it also created a reduction of 12 million tonnes of CO2, contributing significantly to sustainability goals.
This campaign helped employees embrace new norms around travel, fostering a more sustainable, empowered, and thoughtful culture around when and how to meet.
This project was recognised by the Institute of Internal Communication (IoIC) for Best Change/Transformation.
Jump to a slide with the slide dots.
New Emota and IPCAA research of 251 healthcare professionals reveals how medical congress engagement must evolve to meet rising HCP expectations.
Read more
Colin Melville
Film director Colin Melville explores why AI video looks fake and how embracing imperfection, camera shake, and raw realism is key to making AI...
Read more
Amy Bennett
Discover 5 principles of patient-centred medical writing and learn how to create authentic, empathetic cancer content that truly resonates with...
Read more
Holly Spencer
300 million people live with rare diseases worldwide. Discover why better patient and clinician experience must sit alongside scientific innovation.
Read more
Emma Crawford
300 million people live with rare diseases worldwide. Discover why better patient and clinician experience must sit alongside scientific innovation.
Read more